MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.76
+0.41 (2.51%)
At close: Jan 16, 2026, 4:00 PM EST
16.75
-0.01 (-0.06%)
After-hours: Jan 16, 2026, 7:58 PM EST

MLTX Stock Forecast

Stock Price Forecast

The 9 analysts that cover MLTX stock have a consensus rating of "Buy" and an average price target of $22.22, which forecasts a 32.58% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $61.

Price Target: $22.22 (+32.58%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$22.22$20$61
Change-70.17%+32.58%+19.33%+263.96%

Analyst Ratings

The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingAug '25Sep '25Oct '25Nov '25Dec '25Jan '26
Strong Buy343444
Buy422222
Hold033221
Sell000000
Strong Sell001112
Total799999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Strong Sell
Downgrades
$8$10
Strong SellDowngrades$8$10-40.33%Jan 15, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$26$32
Strong BuyReiterates$26$32+90.93%Jan 9, 2026
BTIG
BTIG
Strong Buy
Upgrades
$24
Strong BuyUpgrades$24+43.20%Jan 9, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$30$26
Strong BuyMaintains$30$26+55.13%Nov 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$30
Strong BuyUpgrades$30+79.00%Nov 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.63
from -1.89
EPS Next Year
-3.63
from -3.63
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
------41.81M
Revenue Growth
-------
EPS
-8.21-1.70-0.73-1.89-3.63-3.63-3.49
EPS Growth
-------
Forward PE
-------
No. Analysts
----191813
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-3.49-2.66
Avg-3.63-3.63
Low-3.62-4.25

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.